Primary care physicians’ awareness and perceptions on adherence to primary cardiovascular disease prevention guidelines in Lebanon: A cross-sectional study

Abstract

Objectives

To assess the awareness and have an insight on practice patterns of primary care physicians (PCPs) with respect to several professional primary cardiovascular diseases (CVDs) preventive guidelines.

Methods

This is a cross-sectional study, questionnaire-based using a non-probability convenience sampling. Data collection occurred at the annual conferences of the Lebanese Societies of General Practice, Family Medicine, and Internal Medicine in Lebanon. 104 PCPs were recruited.

Main Outcome Measures

Awareness and practices of CVDs preventive guidelines.

Results

The response rate was 37%. Awareness of the various CVD preventive guidelines was high among PCPs (>81%). Around 69% of PCPs reported that they always calculate the total cardiovascular risk assessment score. Gaps in managing patients according to guidelines’ recommendations were higher in statin initiation compared to antihypertensive initiation. There is over prescription of statin in low risk patients and underutilization in high risk patients. Around 20% of PCPs would initiate aspirin for a low risk patient. Around 17% of physicians do not perform abdominal aortic aneurysm screening.

Discussion

Although PCPs demonstrated high level of awareness regarding CVD preventive guidelines, gaps remain present in managing patients according to guidelines’ recommendations. Less adherence to guidelines will increase mortality and affect patient care.

Keywords

Cardiovascular diseases cardiovascular prevention primary prevention guidelines primary care

Get full access to this article

View all access options for this article.

References

Hobbs

Erhardt

Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey.

Fam Pract 2002; 19: 596–604.

Mattioli

Palmiero

Manfrini

, et al. Mediterranean diet impact on cardiovascular diseases: a narrative review. J Cardiovasc Med 2017; 18: 925–935.

World Health Organization (WHO). Noncommunicable Diseases, www.who.int/countries/lbn/en/ (2014, accessed 16 December 2020).

Kotseva

Wood

The challenge for preventive cardiology.

Eur J Cardiovasc Prev Rehabil 2009; 16: S19–S23.

Kabir

Bennett

Shelley

, et al. Comparing primary prevention with secondary prevention to explain decreasing coronary heart disease death rates in Ireland, 1985-2000. BMC Public Health 2007; 7: 117.

World Health Organization (WHO). Prevention of cardiovascular disease: guidelines for assessment and management of cardiovascular risk, http://apps.who.int/iris/bitstream/10665/43685/1/9789241547178_eng.pdf (2007, accessed 16 December 2020).

Pearson

Blair

Daniels

, et al. AHA guidelines for primary prevention of cardiovascular disease and stroke: 2002 Update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation 2002; 106: 388–391.

Stone

Robinson

Lichtenstein

, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 129: S1–S45.

James

Oparil

Carter

, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). J Am Med Assoc 2014; 311: 507–520.

10.

National Institutes of Health. ATP III guidelines at-a-glance quick desk reference. NIH publication. 2001 May:01-3305, http://www.nhlbi.nih.gov/files/docs/guidelines/atglance.pdf (May 2001, accessed 16 December 2020).

11.

Force USPST. Statin use for the primary prevention of cardiovascular disease in adults: preventive medication, www.uspreventiveservicestaskforce.org/uspstf/recommendation/statin-use-in-adults-preventive-medication (2016, accessed 20 March 2020).

12.

Fifth Joint Task Force of the European Society of C, European Association of E, European Association of Percutaneous Cardiovascular Iet al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur J Prev Cardiol 2012; 19: 585–667.

13.

Shi

The impact of primary care: a focused review.

Scientifica (Cairo) 2012; 2012: 432892.

14.

Doroodchi

Abdolrasulnia

Foster

, et al. Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events. BMC Fam Pract 2008; 9: 42.

15.

Jiang

Hong

, et al. Knowledge of secondary prevention guidelines for coronary heart disease: results from a physicians' survey in China. Eur J Prev Cardiol 2012; 19: 991–998.

16.

Reiner

Sonicki

Tedeschi-Reiner

Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey.

Atherosclerosis 2010; 213: 598–603.

17.

Dallongeville

Banegas

Tubach

, et al. Survey of physicians' practices in the control of cardiovascular risk factors: the EURIKA study. Eur J Prev Cardiol 2012; 19: 541–550.

18.

Heidrich

Behrens

Raspe

, et al. Knowledge and perception of guidelines and secondary prevention of coronary heart disease among general practitioners and internists. Results from a physician survey in Germany. Eur J Cardiovasc Prev Rehabil 2005; 12: 521–529.

19.

Hobbs

Erhardt

Fam Pract 2002; 19: 596–604.

20.

Mosca

Linfante

Benjamin

, et al. National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation 2005; 111: 499–510.

21.

ACo Cardiology. Calculate your 10-year risk of heart disease or stroke using the ASCVD algorithm, www.cvriskcalculator.com/ (2013, accessed 10 October 2020).

22.

Dresselhaus

Peabody

Luck

, et al. An evaluation of vignettes for predicting variation in the quality of preventive care. J Gen Intern Med 2004; 19: 1013–1018.

23.

Liguori

Moreira

LFP.

Operating with data-statistics for the cardiovascular surgeon: part II. Association and risk.

Braz J Cardiovasc Surg 2018; 33: IV–VIII.

24.

Steinman

Fischer

Shlipak

, et al. Clinician awareness of adherence to hypertension guidelines. Am J Med 2004; 117: 747–754.

25.

van Staa

T-P

Smeeth

, et al. The efficiency of cardiovascular risk assessment: do the right patients get statin treatment? Heart 2013: 99: 1597–1602.

26.

Webster

Heeley

Peiris

, et al. Gaps in cardiovascular disease risk management in Australian general practice. Med J Aust 2009; 191: 324–329.

27.

Siu

A new way of targeting to treat coronary artery disease.

J Cardiovasc Med 2010; 11: 1–6.

28.

Howard

PA.

Aspirin for primary cardiovascular prevention: when is it worth the risks?

Hosp Pharm 2014; 49: 502–507.

29.

Sposito

Ramires

Jukema

, et al. Physicians' attitudes and adherence to use of risk scores for primary prevention of cardiovascular disease: cross-sectional survey in three world regions. Curr Med Res Opin 2009; 25: 1171–1178.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.16 MB

0.05 MB